These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical strategies in the treatment of Alzheimer's disease. Swaab DF; Fliers E Prog Brain Res; 1986; 70():413-27. PubMed ID: 2883704 [No Abstract] [Full Text] [Related]
3. Psychopharmacology of Alzheimer's disease. Procter AW Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):191-4. PubMed ID: 8777499 [No Abstract] [Full Text] [Related]
4. Psychopharmacological approaches to the organic brain syndrome. Lehmann HE Compr Psychiatry; 1983; 24(5):412-30. PubMed ID: 6138211 [No Abstract] [Full Text] [Related]
5. [Pharmacological correction of Alzheimer's disease (review of the literature)]. Groppa SA Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):110-6. PubMed ID: 1686127 [No Abstract] [Full Text] [Related]
6. [Drug therapy of Alzheimer's disease. Problems and strategy in development of new therapeutic drugs for Alzheimer's disease]. Moroji T; Matsuzaki I Nihon Rinsho; 1988 Jul; 46(7):1586-91. PubMed ID: 2906096 [No Abstract] [Full Text] [Related]
7. Therapeutic progress--review XVIII Alzheimer's disease. Kendall MJ; Chellingsworth MC; Main AN J Clin Hosp Pharm; 1985 Dec; 10(4):327-36. PubMed ID: 2869054 [No Abstract] [Full Text] [Related]
8. Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets. Prakash A; Kalra J; Mani V; Ramasamy K; Majeed AB Expert Rev Neurother; 2015 Jan; 15(1):53-71. PubMed ID: 25495260 [TBL] [Abstract][Full Text] [Related]
9. Psychopharmacology and Alzheimer's disease. Serby M J Adv Med Surg Nurs; 1989 Mar; 1(2):32-9. PubMed ID: 2664071 [No Abstract] [Full Text] [Related]
10. [Drug therapy of Alzheimer's disease using neurotransmitter-related substances]. Nakamura S Nihon Rinsho; 1988 Jul; 46(7):1580-5. PubMed ID: 2906095 [No Abstract] [Full Text] [Related]
11. Drug abuse? Use and misuse of psychotropic drugs in Alzheimer's care. Taft LB; Barkin RL J Gerontol Nurs; 1990 Aug; 16(8):4-10. PubMed ID: 2201718 [TBL] [Abstract][Full Text] [Related]
12. The effectiveness of amiridin in senile dementia of the Alzheimer's type. Bukatina EE; Grigor'eva IV; Sokol'chik EI Neurosci Behav Physiol; 1993; 23(1):83-9. PubMed ID: 8464548 [No Abstract] [Full Text] [Related]
13. Nootropics and metabolically active compounds in Alzheimer's disease. Nicholson CD Biochem Soc Trans; 1989 Feb; 17(1):83-5. PubMed ID: 2653923 [No Abstract] [Full Text] [Related]
14. Alternatives for Alzheimer's. Three basic approaches offer help and hope. Reese D Contemp Longterm Care; 2002 Feb; 25(2):8-9. PubMed ID: 11842532 [No Abstract] [Full Text] [Related]
15. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease. Orsel K; Taipale H; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Gardarsdottir H; Hartikainen S Eur Neuropsychopharmacol; 2018 Nov; 28(11):1260-1269. PubMed ID: 30153953 [TBL] [Abstract][Full Text] [Related]
16. A research agenda for disruptive behaviors in Alzheimer's disease: a combined biomedical and behavioral approach. Raskind M Int Psychogeriatr; 1996; 8 Suppl 1():53-8. PubMed ID: 8934266 [No Abstract] [Full Text] [Related]
17. [Drug therapy of Alzheimer's disease]. Sulkava R Duodecim; 2000; 116(24):2867-73. PubMed ID: 12077892 [No Abstract] [Full Text] [Related]
19. A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland. Moga DC; Taipale H; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S; Wu Q; Jicha GA; Gnjidic D Drugs Aging; 2017 Jan; 34(1):55-65. PubMed ID: 27896799 [TBL] [Abstract][Full Text] [Related]
20. Approved drugs are to be studied for use in Alzheimer's disease. Hopkins Tanne J BMJ; 2016 Sep; 354():i5063. PubMed ID: 27644990 [No Abstract] [Full Text] [Related] [Next] [New Search]